Cambodia’s Phnom Penh authorities have ordered extending the night curfew by seven days to August 19. (Photo: Khmer Times) “A curfew is imposed, temporarily suspending alltraffic and business activities between 22.00 and 3.00 hours for seven daysfrom zero on August 13, 2021 to August 19, 2021,” Khmer Times quoted a documentissued by the local administration as saying.
In addition, the decision states that activities,occupations or businesses at high risk of spreading COVID-19 are temporarilysuspended for 14 days, from August 13-26.
The decision targets schools, both public and private;all kinds of clubs, including karaoke, bars, discos, beer gardens and casinos; resorts,museums, playgrounds and parks; massage, sauna and all kinds of business; allkinds of shops and liquor stores; and cinemas, art theaters, gyms and all kindsof sports centers.
The Cambodian Ministry of Health on August 11 morningreported 486 new COVID-19 cases and 12 deaths, pushing the national tally to83,384 and the death toll to 1,614.
Meanwhile, the Indonesian Government said on August 11that Jakarta now has no red zones of COVID-19, and all of the capacity city’s localitiesare in orange zones that indicate a medium risk of infection.
Jakarta confirmed 40 fatalities and 1,222 recoveredpatients on the day. A total of 10,520 patients are under treatment in hospitalsor at home.
Bangkok Post said two coronavirus vaccinesadministered using a nasal spray being developed in Thailand are due to starthuman trials by the end of this year, after promising results in trialsinvolving mice.
Developed by the National Center for GeneticEngineering and Biotechnology, the vaccines are based on the adenovirus andinfluenza, the newspaper cited deputy government spokeswoman RatchadaThanadirek as saying on August 11.
After conducting trials in mice, the first phase of humantrials should start by the end of this year, pending approval from the food anddrug regulator, she said.
The trials will also test protection against the Deltavariant, Ratchada said, with the second phase due in March next year and atarget of production for wider use in mid-2022, if results are good, she said.
The country’s vaccination campaign has so far reliedon Sinovac, AstraZeneca and Sinopharm shots./.
VNA
